AACR Journals
@aacrjournals
The American Association for Cancer Research’s 10 peer-reviewed journals provide a renowned, respected forum for publishing the most innovative cancer science, encompassing the full spectrum of basic, translational, clinical, and epidemiological research.
From the latest issue of Molecular Cancer Research: Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation ➡️Read the study: buff.ly/fSkC7rr
Molecular Cancer Therapeutics highlights novel cancer therapies through its #FirstDisclosure article type. These articles present drugs for the first time in published literature. Check out recently published First Disclosures: buff.ly/FleTsdi
Phase 3 Study Analysis: AR and non-AR Alterations in the ctDNA of mCRPC Patients from the Alliance A031201 trial, in Clinical Cancer Research. buff.ly/Z8vcBRK
From the July issue of Blood Cancer Discovery: Beyond Static Subtypes in Large B-cell Lymphoma: Context, Plasticity, and Therapeutic Logic buff.ly/pbXFnUj
Read the Phase 2 Study: Carboplatin, Cabazitaxel and Abiraterone in mCSPC (NCT03934840, CASCARA), in Clinical Cancer Research. buff.ly/w0BNuPZ
Phase 2 Study: CCL3+ Neutrophil Signature Predicts Neoadjuvant Chemoimmunotherapy Response in HPSCC (ChiCTR2400081826), in Clinical Cancer Research. buff.ly/DC0Mp0k
In Cancer Epidemiology, Biomarkers & Prevention: Optimizing the Uptake and Completion of the Cervical Cancer Screening Continuum: Opportunity Knocks, Including at Home. buff.ly/wV4DOz8
The AACR Journals offers the Guaranteed Peer Review program. Members who peer review at least three manuscripts for one or more AACR journals can qualify to have their own submitted manuscript be automatically sent for external peer review. 👉 Learn more: buff.ly/mivP542
Phase 3 Study: Pegylated Liposomal Doxorubicin for Advanced and Refractory Desmoid Tumors (NCT05561036), in Clinical Cancer Research. buff.ly/hE3mlU1
Read article collections, featuring impactful, cutting-edge research, that complement the information presented at the AACR Meetings. buff.ly/aH9TnuL
Read studies highlighted in the Pediatric Cancer collection: buff.ly/Lx8DRrK
Welcome Molecular Cancer Therapeutics Senior Editor Anthony Rullo, MSc, PhD, who brings expertise in medicinal chemistry, physical biochemistry, bio-orthogonal affinity labeling chemistry, and tumor immunology. Learn more about the journal: buff.ly/SvrkEMr
In Clinical Cancer Research, read: Association of TILs with Clinical Characteristics and Prognosis in Young Women with HR+/HER2- Breast Cancer. buff.ly/GncFEwv
Read the Phase 1b Study: Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma (Cohort 7A of NCT03277924), in Clinical Cancer Research. buff.ly/YUe3w2Y
Read the July issue of Molecular Cancer Therapeutics: buff.ly/dF8cMvl
Welcome Molecular Cancer Therapeutics Senior Editor Fleur M. Ferguson, PhD, who brings expertise in drug discovery technologies, molecular pharmacology, and chemistry and chemical biology. Learn more about the journal: buff.ly/SvrkEMr @fleurmferguson.bsky.social
From Blood Cancer Discovery: Multiplexed Spatial Profiling of the Myeloma Bone Marrow buff.ly/WCtCCcO Imaging mass cytometry of patient-derived multiple myeloma bone marrow biopsies identifies spatial features associated with bone disease, metabolic programs, and progression-free survival.
Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019. Read the article in Cancer Epidemiology, Biomarkers & Prevention. buff.ly/f0fBC4R
In the June issue of Cancer Epidemiology, Biomarkers & Prevention: Opportunistic Screening of High-Risk Breast Cancer Variants in Hospital Biobank Setting. buff.ly/5mN1pZU
Alia Sajani, PhD, Assistant Editor for Cancer Immunology Research, is attending the Cancer Immunology: Across Space & Time Conference and would love to hear about your research. Connect with her to discuss publishing opportunities in the Journals. #CancerImmuno @fusionconf.bsky.social
Read the new Cancer Research Resources article featured in the July issue of Molecular Cancer Research: ➡️ Gastric Epithelium from BRCA1 and BRCA2 Carriers Harbors Increased Double-Stranded DNA Damage and Enhanced Growth Potential, by Bryson Katona and colleagues buff.ly/MlEN3jW
Phase 3 Study Analysis: Patient-Reported Outcomes from FLAURA2 (NCT04035486), in the June issue of Clinical Cancer Research. buff.ly/FBjluED
Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/MPqGjG9
Read the Phase 2 Study in Clinical Cancer Research: Eribulin in Vascular Sarcomas (NCT03331250 and ACTRN12618000357257). buff.ly/KoNwgFh